# Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

> **NCT04680130** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 500 (estimated)

## Conditions studied

- PSP
- CBD
- PCA
- LPA
- Semantic Dementia
- Semantic Aphasia
- Behavioral Variant of Frontotemporal Dementia
- FTD
- PPA
- Apraxia of Speech
- MSA - Multiple System Atrophy
- Parkinson Disease

## Interventions

- **DRUG:** C-11 PiB
- **DRUG:** AV1451 Tau
- **DRUG:** C-11 ER176

## Key facts

- **NCT ID:** NCT04680130
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-11-01
- **Primary completion:** 2050-11
- **Final completion:** 2050-11
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04680130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04680130, "Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04680130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*